[What's new in pediatric dermatology?]

Abstract

The year 2017 in pediatric dermatology was marked by several consensus recommendations and meta analyzes on childhood psoriasis, atopic dermatitis or PHACE syndrome, case series on the role of anti-JAK treatment in adolescent with alopecia areata, sirolimus for vascular malformations, ivermectine for rosacea, inhibitors of MEK for type 1 neurofibromatosis or on the side effects of the oral isotretinoin for acne or propranolol for immature hemangioma. Only few randomized controlled studies have been published on the interest of adalimumab in the treatment of psoriasis or topical sirolimus for angiofibroma in tuberous sclerosis complex for example. There were also clinical articles on various affections such as the sign of the scalp hair collar sign, childhood prurigo, ichthyosis, atopic dermatitis, warts or Zika virus infection. Finally, numerous publications reported new genes responsible for dermatosis in mosaics with new questionings and perspectives.

Keywords: Acne; Acné; Alopecia Areata; Atopic Dermatitis; Dermatite atopique; Dermatologie; Dermatology; Hémangiome; Infantile Hemangioma; Malformations vasculaires; Mosaic; Mosaïque; Neurofibromatose; Neurofibromatosis; Paediatric; Pelade; Psoriasis; Pédiatrie; Vascular Malformation.